Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines
Sponsor
University of Patras (Other)
Overall Status
Completed
CT.gov ID
NCT04954651
Collaborator
(none)
1,000
1
8.7
115.3
Study Details
Study Description
Brief Summary
Patients who voluntarily visit vaccination centers in Greece against COVID-19 are recruited and their immunization levels against Sars-Cov2 are assesed by measurement of the levels of serum antibodies against Sars-cov-2 before vaccination and in time intervals up to 6-9 months post-vaccination (indicatively 0-1-3-6-9 months post-vaccination).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received European Union (EU) -Approved COVID-19 Vaccines
Actual Study Start Date
:
Jul 7, 2021
Actual Primary Completion Date
:
Mar 28, 2022
Actual Study Completion Date
:
Mar 28, 2022
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
VAC Vaccinated subject against Sars-Cov2 |
Biological: Approved vaccines against Sars-Cov2
Subjects who voluntarily are vaccinated against Sars-Cov-2 with any of the approved vaccines by EU
|
Outcome Measures
Primary Outcome Measures
- Antibody titer against Sars-Cov2 [0-9 months]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Subjects who voluntarily receive COVID-19 vaccination
Exclusion Criteria:
-
Patients who do not complete their vaccination
-
Patients who do not provide info on their health status
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital of Patras | Patras | Greece | 26504 |
Sponsors and Collaborators
- University of Patras
Investigators
- Principal Investigator: Ioannis Habeos, MD, PhD, University of Patras
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Ioannis Habeos,
Professor,
University of Patras
ClinicalTrials.gov Identifier:
NCT04954651
Other Study ID Numbers:
- 99-25/2/2021
First Posted:
Jul 8, 2021
Last Update Posted:
Jun 6, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ioannis Habeos,
Professor,
University of Patras
Additional relevant MeSH terms: